Home

Mehul Joshi

CIK 1939602 · Chief Financial Officer & PAO · last filed 2025-09-03

Mehul Joshi is a Chief Financial Officer & PAO who has filed 10 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing shows the insider sold $12.7K of LUNG on Sep 3, 2025. Across all open-market trades the lifetime net is −$140.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $265.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$265.2K

Companies

3

Total Filings

10

Lifetime Open-Market Net

-$140.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LUNG Chief Financial Officer & PAO 212,154 $1.25 $265.2K -$140.3K 4 2025-09-03
Bruker Cellular Analysis, Inc. (CELL) Delisted Chief Financial Officer 65,013 $1.00 $64.9K $0 3 2023-10-03
Bruker Cellular Analysis, Inc. (BLI) Delisted Chief Financial Officer 516,942 $1.20 $620.3K $0 2 2023-03-07

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-09-03 LUNG Sell (S) −7,936 -$12.7K EDGAR
2025-06-04 LUNG Sell (S) −8,061 -$25.2K EDGAR
2025-03-05 LUNG Mixed +93,616 -$102.4K EDGAR
2024-05-07 LUNG Grant (A) +125,870 $0 EDGAR
2023-10-03 Bruker Cellular Analysis, Inc. (CELL) Delisted Mixed −840,530 $0 EDGAR
2023-07-28 Bruker Cellular Analysis, Inc. (CELL) Delisted Tax (F) −26,412 -$14.5K EDGAR
2023-07-26 — Notice (144) −26,412 -$14.7K EDGAR
2023-06-01 Bruker Cellular Analysis, Inc. (CELL) Delisted Grant (A) +350,000 $0 EDGAR
2023-03-07 Bruker Cellular Analysis, Inc. (BLI) Delisted Mixed +227,586 -$24.4K EDGAR
2022-07-26 Bruker Cellular Analysis, Inc. (BLI) Delisted Grant (A) +287,356 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.